Home » Authors » Tiffany Turner

Tiffany Turner

Articles

ARTICLES

Middlebrook Gets $100M and a New Management Team

Nov. 1, 2011

By Tiffany Turner

No Abstract

IDM Pleased with Data from Osteosarcoma Program

Nov. 1, 2011

By Tiffany Turner

No Abstract

LigoCyte Sets Series C Terms: $28M for Vaccine Development

Nov. 1, 2011

By Tiffany Turner

No Abstract

NewCo News: Cortria Aims to Capitalize on Dyslipidemia Market

July 21, 2008

By Tiffany Turner

BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions

July 17, 2008

By Tiffany Turner

Avastin, Tarceva Sales Boost Genentech's Quarterly Earnings

July 16, 2008

By Tiffany Turner

Neurogen Halts Dosing of Adipiplon in Insomnia

July 15, 2008

By Tiffany Turner

Big Pharmas Team Up to Link Technology and Business Needs

July 11, 2008

By Tiffany Turner

SGX Shares Soar on Merger Giving Lilly Technology Boost

July 10, 2008

By Tiffany Turner

Seattle Genetics Nets $4M in Deal with Daiichi Sankyo

July 9, 2008

By Tiffany Turner

View All Articles by Tiffany Turner

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...